Depression Treatment: No Association of Genetic Variants in BDNF With Major Depression: A Meta- and Gene-Based Analysis.
No association of genetic variants in BDNF with major depression: A meta- and gene-based analysis.
Filed under: Depression Treatment
Am J Med Genet B Neuropsychiatr Genet. 2012 Nov 26;
Gyekis JP, Yu W, Dong S, Wang H, Qian J,… Continue reading
Depression in Epilepsy: A Systematic Review and Meta-Analysis.
Depression in epilepsy: A systematic review and meta-analysis.
Filed under: Depression Treatment
Neurology. 2012 Nov 21;
Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, Bulloch AG, Jette N
ABSTRACT OBJECTIVE: To estimate the prevalence of… Continue reading
Does Maternal Depression Predict Young Children’s Executive Function? – a 4-Year Longitudinal Study.
Does maternal depression predict young children’s executive function? – a 4-year longitudinal study.
Filed under: Depression Treatment
J Child Psychol Psychiatry. 2012 Nov 22;
Hughes C, Roman G, Hart MJ, Ensor R
Background:? Building on reports that parental maltreatment… Continue reading
Mindfulness and Bodily Distress.
Mindfulness and bodily distress.
Filed under: Depression Treatment
Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO
We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading
Source Population Characteristics Affect Heterosis Following Genetic Rescue of Fragmented Plant Populations.
Source population characteristics affect heterosis following genetic rescue of fragmented plant populations.
Filed under: Depression Treatment
Proc Biol Sci. 2013 Jan 7; 280(1750): 20122058
Pickup M, Field DL, Rowell DM, Young AG
Understanding the relative importance of heterosis and… Continue reading
Nasal Backflow and the Difficulty of Relaxation in the Upper Esophageal Sphincter.
Nasal backflow and the difficulty of relaxation in the upper esophageal sphincter.
Filed under: Rehab Centers
Laryngoscope. 2012 Nov 20;
Park JW, Kwon BS, Chang JH, Sim KB
OBJECTIVES/HYPOTHESIS: Nasal backflow is the regurgitation of material into nasopharynx during… Continue reading
COURSE and RISK FACTORS of FUNCTIONAL IMPAIRMENT in SUBTHRESHOLD DEPRESSION and ANXIETY.
COURSE AND RISK FACTORS OF FUNCTIONAL IMPAIRMENT IN SUBTHRESHOLD DEPRESSION AND ANXIETY.
Filed under: Depression Treatment
Depress Anxiety. 2012 Nov 16;
Karsten J, Penninx BW, Verboom CE, Nolen WA, Hartman CA
BACKGROUND: Although persons with subthreshold depression or anxiety… Continue reading
VAL66MET BDNF GENOTYPES in MELANCHOLIC DEPRESSION: EFFECTS on BRAIN STRUCTURE and TREATMENT OUTCOME.
VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME.
Filed under: Depression Treatment
Depress Anxiety. 2012 Nov 16;
Cardoner N, Soria V, Gratacòs M, Hernández-Ribas R, Pujol J, López-Solà M, Deus J, Urretavizcaya M, Estivill… Continue reading